JSP
BIIB icon

Jackson Square Partners’s Biogen BIIB Stock Holding History

Jackson Square Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25
Closed -$6K – 97
2021
Q1 		$6K Hold
25
– – ﹤0.01% 101
2020
Q4 		$6K Hold
25
– – ﹤0.01% 101
2020
Q3 		$7K Hold
25
– – ﹤0.01% 85
2020
Q2 		$6K Sell
25
-6,920
-100% -$2.08M ﹤0.01% 88
2020
Q1 		$2.2M Sell
6,945
-1,495
-18% -$454K 0.01% 76
2019
Q4 		$2.5M Sell
8,440
-969,416
-99% -$269M 0.01% 75
2019
Q3 		$228M Sell
977,856
-58,074
-6% -$13.5M 1.25% 28
2019
Q2 		$242M Sell
1,035,930
-283,856
-22% -$65.5M 1.25% 27
2019
Q1 		$312M Sell
1,319,786
-597,888
-31% -$188M 1.71% 26
2018
Q4 		$577M Sell
1,917,674
-324,104
-14% -$103M 3.54% 4
2018
Q3 		$792M Buy
2,241,778
+121,072
+6% +$41.7M 4% 5
2018
Q2 		$616M Buy
2,120,706
+123,007
+6% +$34.6M 3.14% 6
2018
Q1 		$547M Sell
1,997,699
-68,323
-3% -$21.2M 2.74% 10
2017
Q4 		$658M Sell
2,066,022
-183,231
-8% -$58.8M 3.34% 5
2017
Q3 		$704M Buy
2,249,253
+191,526
+9% +$56.7M 3.42% 7
2017
Q2 		$558M Sell
2,057,727
-140,293
-6% -$37.1M 2.85% 14
2017
Q1 		$601M Sell
2,198,020
-58,699
-3% -$16.6M 2.95% 12
2016
Q4 		$640M Sell
2,256,719
-315,870
-12% -$93.6M 3.31% 9
2016
Q3 		$805M Sell
2,572,589
-135,684
-5% -$40.2M 3.61% 8
2016
Q2 		$729M Sell
2,708,273
-101,149
-4% -$26.7M 3.06% 14
2016
Q1 		$806M Buy
2,809,422
+271,970
+11% +$71.8M 3.23% 11
2015
Q4 		$874M Buy
2,537,452
+522,771
+26% +$150M 3.23% 10
2015
Q3 		$588M Buy
2,014,681
+195,512
+11% +$64.6M 2.69% 17
2015
Q2 		$735M Buy
1,819,169
+780,847
+75% +$313M 2.81% 14
2015
Q1 		$438M Buy
+1,038,322
New +$409M 1.68% 27

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Jackson Square Partners's BIIB Position: Q2 2021 in Review

Jackson Square Partners sold out of Biogen (BIIB) in Q2 2021, closing a stake of 25 shares — an estimated $6K sold.

Jackson Square Partners first reported a position in BIIB in Q1 2015 and held it in 25 quarters. The position peaked at $874M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Jackson Square Partners reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Jackson Square Partners sold 25 Biogen shares in Q2 2021, an estimated $6K.
  • Jackson Square Partners first reported a position in Biogen in Q1 2015 and held it in 25 quarters.
  • Jackson Square Partners's Biogen position peaked at $874M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Jackson Square Partners's 13F filing for Q2 2021, filed 13 Aug 2021.